Sign Up to like & get
recommendations!
0
Published in 2018 at "Haemophilia"
DOI: 10.1111/hae.13510
Abstract: The therapeutic options for people with haemophilia (PWH) have rapidly evolved in the last 5 years. Moving on from conventional plasma‐derived and recombinant clotting factor concentrates (CFC), there now are extended half‐life CFCs (~1.8× for…
read more here.
Keywords:
haemophilia;
haemostasis;
global perspective;
emerging therapies ... See more keywords